Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets, Reuters reported.
The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies.
The recall is being initiated in the United States and will extend to Europe, Asia, North and South America, Mylan said.
The recalled product was manufactured by Meridian Medical Technologies, a Pfizer Inc company, and distributed by Mylan between December 2015 and July 2016.
Photo Credit: AP Photo/Mark Zaleski, File
from NBC New York - Top Stories http://ift.tt/2ojAAle
source IFTTT
